🔗 Permalink

Inventor profile of:

VERTEX PHARMACEUTICALS INCORPORATED

City:

Country:

United States

Published Applications:

Last publication date:

2014-04-24

Top Assignees for applications by VERTEX PHARMACEUTICALS INCORPORATED

The entities that hold a legal rights for patent applications filed by inventor VERTEX PHARMACEUTICALS INCORPORATED:

VERTEX PHARMACEUTICALS INCORPORATED 10 Cambridge, MA United States
VERTEX PHARMACEUTICALS INCORPORATED 1 Boston, MA United States

Recent patent applications by VERTEX PHARMACEUTICALS INCORPORATED

VERTEX PHARMACEUTICALS INCORPORATED from , US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2014-04-24

US20140113005A1

Chemistry; metallurgy

COMPOUNDS USEFUL AS INHIBITORS OF ATR KINASE

#2 | 2014-03-06

US20140065103A1

Chemistry; metallurgy

COMPOUNDS AND METHODS FOR THE TREATMENT OR PREVENTION OF FLAVIVIRIDAE VIRAL INFECTIONS

#3 | 2014-02-13

US20140044802A1

Human necessities

COMPOUNDS USEFUL AS INHIBITORS OF ATR KINASE AND COMBINATION THERAPIES THEREOF

#4 | 2014-02-06

US20140038935A1

Chemistry; metallurgy

DIHYDRODIAZEPINES USEFUL AS INHIBITORS OF PROTEIN KINASES

#5 | 2014-02-06

US20140037754A1

Chemistry; metallurgy

AMINOPYRIMIDINES USEFUL AS KINASE INHIBITORS

#6 | 2013-12-12

US20130331310A1

Chemistry; metallurgy

Prodrug of an ice inhibitor

#7 | 2013-11-28

US20130317060A1

Chemistry; metallurgy

Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide

#8 | 2013-11-28

US20130316945A1

Chemistry; metallurgy

INHIBITORS OF SERINE PROTEASES, PARTICULARLY HCV NS3-NS4A PROTEASE

#9 | 2013-11-21

US20130310418A1

Chemistry; metallurgy

Azaindazoles useful as inhibitors of kinases

#10 | 2013-10-17

US20130274180A1

Human necessities

Pharmaceutical Compositions

#11 | 2013-08-29

US20130224293A1

Human necessities

PHARMACEUTICAL COMPOSITION AND ADMINISTRATIONS THEREOF

InventorID:

413966 ⎘